Showing 281 - 300 results of 1,014 for search 'development reprogramming', query time: 0.11s Refine Results
  1. 281

    Lactylation-mediated miRNA regulation in cancer therapy resistance by Yiyi Shou, Ruiqi Liu, Hao Xiong, Xiaoyan Chen, Luanluan Huang, Ran Huang, Hailong Sheng, Haibo Zhang, Yanwei Lu, Haiwei Guo

    Published 2025-08-01
    “…We begin with a focused overview of tumour metabolic reprogramming and the enzymology of lactylation, establishing the biochemical context for its regulatory functions. …”
    Get full text
    Article
  2. 282
  3. 283

    GLS1‐Mediated Redundancy in Glutamate Accelerates Arterial Calcification via Activating NMDAR/Ca2+/β‐Catenin Pathway by Ziting Zhou, Bing Dong, Dayu He, Jianshuai Ma, Yun Kong, Huijin Zhu, Chen Xie, Tiecheng Yang, Xin Zhen, Zhengzhipeng Zhang, Zhaohui He, Jinkun Cheng, Aoran Huang, Jie Chen, Ruo Wu, Huiyong Yin, Yanlian Chen, Jun Tao, Hui Huang

    Published 2025-06-01
    “…Treatment with GLS1 inhibitors or knockdown of GLS1 alleviates osteogenic reprogramming. In contrast, glutamate administration boosts the development of arterial calcification. …”
    Get full text
    Article
  4. 284
  5. 285

    Immunosuppressive mechanisms and therapeutic targeting of regulatory T cells in ovarian cancer by Jing Li, Haojun Huang, Renxian Xie, Rongying Yang, Haitao Wang, Li Wan

    Published 2025-07-01
    “…By elucidating the dynamic crosstalk between Tregs and the ovarian TME, this review provides a framework for developing novel immunotherapies to overcome Treg-mediated immunosuppression and improve clinical outcomes.…”
    Get full text
    Article
  6. 286

    Urea cycle dysregulation: a new frontier in cancer metabolism and immune evasion by Yiyi Shou, Ruiqi Liu, Hao Xiong, Keke Xu, Xiaoyan Chen, Luanluan Huang, Yitian Zhang, Hailong Sheng, Haibo Zhang, Yanwei Lu

    Published 2025-07-01
    “…Abstract Cancer cells experience metabolic reprogramming to enhance the synthesis of nitrogen and carbon, facilitating the production of macromolecules essential for tumor proliferation and growth. …”
    Get full text
    Article
  7. 287

    Classification of the LC4 Primarily-like Cell Line—Recapitulating a CDK4 Overexpressing Immune Evasive HIV-HCV-Induced HCC by Janine Kah, Lisa Staffeldt, Tassilo Volz, Kornelius Schulze, Asmus Heumann, Götz Rövenstrunk, Meike Goebel, Sven Peine, Maura Dandri, Stefan Lüth

    Published 2025-04-01
    “…HCC is characterized by high heterogeneity and, subsequently, adaptation by developing resistance to current treatments. Applying individualized models is crucial to understanding the potential of approved therapies. …”
    Get full text
    Article
  8. 288
  9. 289
  10. 290

    Construction of a Dataset for All Expressed Transcripts for Alzheimer’s Disease Research by Zhenyu Huang, Bocheng Shi, Xuechen Mu, Siyu Qiao, Gangyi Xiao, Yan Wang, Ying Xu

    Published 2024-11-01
    “…This work supports future research into gene regulation and metabolic reprogramming in AD and serves as a foundation for exploring novel therapeutic targets.…”
    Get full text
    Article
  11. 291
  12. 292

    A VersaTile Approach to Reprogram the Specificity of the R2-Type Tailocin Towards Different Serotypes of <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> by Dorien Dams, Célia Pas, Agnieszka Latka, Zuzanna Drulis-Kawa, Lars Fieseler, Yves Briers

    Published 2025-01-01
    “…<b>Conclusions:</b> This work lays the groundwork for a scalable platform for the development of engineered tailocins, marking an important step towards making R2 tailocins a practical therapeutic tool for targeted bacterial infections.…”
    Get full text
    Article
  13. 293
  14. 294

    TsR-0072 inhibits colorectal cancer progression through modulating lipid and vitamin D3 metabolic reprogramming and inactivating the Wnt/β-catenin signalling pathway by Qianyi Qi, Bairong Chen, Jinran Wu, Jing Xu, Hongyi Bao, Kangfeng Jin, Lin Chen, Guang Zhu, Feng Wang

    Published 2025-12-01
    “…Background tRNA-derived small RNAs (tsRNAs), newly developed non-coding RNAs with specialized biological features, are aberrantly expressed in the majority of malignancies. …”
    Get full text
    Article
  15. 295

    Lactic acid metabolism: gynecological cancer's Achilles’ heel by Ting Zhang, Wenchao Zhou, Tingyu Fan, Yuwei Yuan, Xing Tang, Qunfeng Zhang, Juan Zou, Yukun Li

    Published 2025-05-01
    “…Abstract Lactic acid is significantly expressed in many cancers, including gynecological cancer, and has become a key regulator of the proliferation, development, metastasis and invasion of these cancers. …”
    Get full text
    Article
  16. 296
  17. 297

    Integrative single-cell and spatial transcriptomics uncover ELK4-mediated mechanisms in NDUFAB1+ tumor cells driving gastric cancer progression, metabolic reprogramming, and immune... by Yuwei Sun, Wenyang Nie, Zhikai Xiahou, Xiaojing Wang, Wenjia Liu, Zongkai Liu, Zhiheng Lin, Zhaidong Liu

    Published 2025-07-01
    “…The findings underscored the importance of developing specific therapeutic targets, targeting metabolic reprogramming, and overcoming immune evasion, providing new theoretical foundations.…”
    Get full text
    Article
  18. 298

    Multi-omics analysis reveals Jianpi formula-derived bioactive peptide-YG-22 potentially inhibited colorectal cancer via regulating epigenetic reprogram and signal pathway regulatio... by Jun Wang, Jun Wang, Lijuan Zhu, Yuanyuan Li, Mingming Ding, Xiyu Wang, Bo Xiong, Hongyu Chen, Lisheng Chang, Wenli Chen, Bo Han, Jun Lu, Qin Shi

    Published 2025-03-01
    “…Furthermore, this study also lays the foundation for further development of peptide-based therapies and highlights the value of combining traditional and modern therapeutic strategies for CRC management.…”
    Get full text
    Article
  19. 299

    Emerging Insights into Sall4’s Role in Cardiac Regenerative Medicine by Jianchang Yang

    Published 2025-01-01
    “…Recent research highlights Sall4’s emerging roles in modulating cardiac progenitors and cellular reprogramming, linking its functions to early heart development and regenerative medicine. …”
    Get full text
    Article
  20. 300